Protagonist Therapeutics, Inc.【PTGX】 業績推移・財務諸表

(単位:千ドル) 2Q16 3Q16 4Q16 1Q17 2Q17 3Q17 4Q17 1Q18 2Q18 3Q18 4Q18 1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 1Q21 2Q21 3Q21 1Q22 2Q22 3Q22 1Q23 2Q23 3Q23 1Q24 2Q24 3Q24 1Q25
売上高 - - - - - 8,781 - - - 6,117 2,353 1,560 - - - - - - - - 10,286 25,722 859 - - - - 254,953 4,167 4,675 28,321
売上成長率(%) - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
研究開発費 5,696 5,561 - 11,282 12,007 11,168 - 15,368 17,735 12,145 - 12,444 19,355 17,293 - 18,768 20,257 15,995 24,245 26,432 36,956 36,318 34,611 25,402 27,416 33,182 30,664 33,734 33,520 35,970 35,893
営業費用 7,091 7,138 - 14,273 15,131 13,761 - 19,010 20,913 15,506 - 16,208 23,218 21,308 - 23,344 24,434 20,886 30,210 33,147 44,212 46,833 42,302 32,303 36,021 42,354 38,326 48,644 42,960 46,128 47,631
営業利益 -7,091 -7,138 -11,397 -14,273 -15,131 -4,980 -3,513 -8,229 -9,239 -9,389 -15,412 -14,648 -31,407 -17,167 -17,299 -19,697 -18,217 -7,772 -24,021 -30,882 -33,926 -21,111 -41,443 -32,303 -36,021 -42,354 -38,326 206,309 -38,793 -41,453 -19,310
営業利益率 (%) - - - - - - - - - - - - - - - - - - - -
経常(税引前)利益 - - - - - - - - - - - -13,920 -30,803 -16,511 - -19,904 -18,292 -7,763 -23,998 -30,842 -33,804 - - - - - - 210,666 -31,292 -33,630 -11,655
経常(税引前)利益率(%) - - - - - - - - - - - -892.31 - - - - - - - - -328.64 - - - - - - 82.63 -750.95 -719.36 -41.15
法人税等合計 - - - - - - - - - - - 200 -1,629 -102 - 176 1,100 - - - - - - - - - - 3,300 -700 -400 -
実効税率(%) - - - - - - - - - - - - - - - - - - - - - - -
純利益 -7,098 -7,084 -11,248 -14,101 -14,979 -4,825 -3,052 -7,661 -8,663 -8,735 -13,865 -14,103 -29,174 -16,409 -17,501 -20,080 -19,421 -7,763 -23,998 -30,842 -33,804 -20,930 -41,037 -31,232 -33,725 -38,460 -34,105 207,340 -30,616 -33,210 -11,655
純利益率(%) - - - - - - - - - - - - - - - - - - - -
一株あたり利益 - - - - - - - - - - - - - - - - - - - - - -0.43 -0.84 -0.64 -0.67 -0.68 -0.58 3.41 -0.5 -0.54 -0.19
希薄化後一株あたり利益 - - - - - - - - - - - - - - - - - - - - - -0.43 -0.84 -0.64 -0.67 -0.68 -0.58 3.26 -0.5 -0.54 -0.19
EBITDA - - - - - - - - - - - - - - - - - - - - - - -
EBITDAマージン(%) - - - - - - - - - - - - - - - - - - - - - - - - - - - -